Li-Tain Yeh, PhD

Arthrosi Therapeutics, Inc.
San Diego, CA, United States

CEO of Arthrosi Therapeutics Inc.

Presentation(s):

• 1112: AR882, a Potent Uricosuric Agent, Shows Favorable Uric Acid Excretion Profile Following Multiple Doses

  Monday, November 13, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.